false
0001818644
0001818644
2026-11-13
2026-11-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 13, 2026
AEYE, INC.
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-39699 |
|
37-1827430 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
| 4670 Willow Road, Suite 125, Pleasanton, California |
|
94588 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (925) 400-4366
|
|
|
|
| |
(Former Name or Former Address, if Changed Since Last Report) |
|
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, par value $0.0001 per share |
|
LIDR |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers. |
(e) On November 13,
2026, the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of AEye, Inc.
(the “Company”) approved a 2027 executive equity program (the “Program”) and awards under the Program to
certain executive officers, including Conor B. Tierney, the Company’s Chief Financial Officer, and recommended that the Board
approve the Program and awards under the Program for Matthew Fisch, the Company’s Chief Executive Officer. On November 13,
2026, on the recommendation of the Committee, the Board approved the Program and the awards for Mr. Fisch. The awards under the
Program constitute the recipients’ annual long-term equity awards for 2027, were made under the Company’s 2021 Equity
Incentive Plan, as amended (the “Plan”), and consist, by target value, of 75% performance stock units
(“PSUs”) and 25% time-based restricted stock units (“RSUs”).
Grant of Performance Stock Units
On November 13, 2026, the
Committee awarded 511,925 PSUs to Mr. Tierney and, on the recommendation of the Committee, the Board awarded 2,047,387 PSUs to Mr. Fisch.
The performance
condition for the PSUs will be satisfied and the PSUs will vest in increments of one-third (1/3) of the total PSUs granted to each
of the executive officers when the average closing price of the Company’s common stock, as reported by NASDAQ (or other
recognized national exchange on which the Company’s common stock is then traded) achieves each of the following milestones:
(i) meets or exceeds an average of $2.00 per share; (ii) meets or exceeds an average of $3.00 per share; and (iii) meets or exceeds
an average of $4.00 per share (in all cases as adjusted for any stock splits or other corporate actions), in each case, over any ten (10)
consecutive trading days beginning on or after the grant date, subject to the executive officer’s continued
service through the date on which the milestone is achieved. Each vested PSU will be settled by the issuance of one share of the
Company’s common stock, and the PSUs do not include any right or option to settle in cash. If the performance condition is not
satisfied prior to December 31, 2031, any PSUs not vested by that date will be forfeited in their entirety. The PSUs are otherwise
governed by the Plan.
Approval of Restricted Stock Units
On November 13, 2026, the
Committee approved the grant of 170,642 RSUs to Mr. Tierney and, on the recommendation of the Committee, the Board approved the grant
of 682,462 RSUs to Mr. Fisch. The RSU grants will become effective on January 15, 2027 without further action by the Committee or the
Board, subject to the executive officer’s continued service through that date. If the number of shares available under the Plan, including the automatic annual increase in the number of shares available under the Plan on January 1, 2027,
is insufficient for all of the RSUs approved under the Program, the RSUs will be reduced pro rata among the participants in the Program.
The RSUs will vest as to one-twelfth
(1/12th) of the RSUs on February 15, May 15, August 15, and November 15 of each year, beginning on February 15, 2027 and ending on November
15, 2029, subject to the executive officer’s continued service through each vesting date. Each vested RSU will be settled by the
issuance of one share of the Company’s common stock. The RSUs are otherwise governed by the Plan.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
AEye, Inc. |
| |
|
|
| Dated: November 17, 2026 |
|
|
| |
By: |
/s/ Siraj Husain |
| |
|
Siraj Husain |
| |
|
VP, General Counsel and Corporate Secretary |